GlaxoSmithKline is officially the first drugmaker to use Apple’s ResearchKit health system to conduct clinical research. To study rheumatoid arthritis, “Glaxo wants to record the mobility
of 300 participants over three months and will also ask the patients to input both physical and emotional symptoms, such as pain and mood,” Bloomberg reports. “The success of the study
could help determine the pharmaceutical industry’s future appetite for using Apple’s products to conduct research.”
Read the whole story at Bloomberg »
